1. Supplementary Figure e-2 Dataset of AQP4-Ab levels for RTX short-term effects.
Data about AQP4-Ab titration corresponding to the short-term analysis are shown in detail. (A) The present panel shows data about AQP4-Ab titers in 28 paired samples at RTX infusion time and after 3 months (N°= number of the corresponding RTX reinfusion cycle), the trend observed in antibody levels, and the classification according to RTX responsiveness. (B) Data about RTX short-term effects are shown for the group of all patients, for the groups of responder and non-responder patients, and for each single subject. (n.d. = not defined).